Related references
Note: Only part of the references are listed.International Histopathology Consensus for Unilateral Primary Aldosteronism
Tracy Ann Williams et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism Implications for Case Detection
Nicholas Yozamp et al.
HYPERTENSION (2021)
Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism
Fumitoshi Satoh et al.
HYPERTENSION RESEARCH (2021)
The Unrecognized Prevalence of Primary Aldosteronism A Cross-sectional Study
Jenifer M. Brown et al.
ANNALS OF INTERNAL MEDICINE (2020)
Primary Aldosteronism in Patients in China With Recently Detected Hypertension
Zhixin Xu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Progress in Primary Aldosteronism 2019: New Players on the Block?
Martin Reincke et al.
HORMONE AND METABOLIC RESEARCH (2020)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension*
Paolo Mulatero et al.
JOURNAL OF HYPERTENSION (2020)
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism
Gian Paolo Rossi et al.
INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION (2020)
18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status
Yuta Tezuka et al.
HYPERTENSION (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
CLCN2 chloride channel mutations in familial hyperaldosteronism type II
Ute I. Scholl et al.
NATURE GENETICS (2018)
A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
Fabio L. Fernandes-Rosa et al.
NATURE GENETICS (2018)
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
Gregory L. Hundemer et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Cellular and Genetic Causes of Idiopathic Hyperaldosteronism
Kei Omata et al.
HYPERTENSION (2018)
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans
Kazutaka Nanba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook
Laurence Amar et al.
ANNALES D ENDOCRINOLOGIE (2016)
Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism
Rene Baudrand et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Activating mutations in CTNNB1 in aldosterone producing adenomas
Tobias Akerstrom et al.
SCIENTIFIC REPORTS (2016)
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
Koshiro Nishimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism
Ute I. Scholl et al.
ELIFE (2015)
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Elena A. B. Azizan et al.
NATURE GENETICS (2013)
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism
Ute I. Scholl et al.
NATURE GENETICS (2013)
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension
Felix Beuschlein et al.
NATURE GENETICS (2013)
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism
Sheerazed Boulkroun et al.
HYPERTENSION (2012)
Expression and Mutations of KCNJ5 mRNA in Japanese Patients with Aldosterone-Producing Adenomas
Ryo Taguchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effect of KCNJ5 Mutations on Gene Expression in Aldosterone-Producing Adenomas and Adrenocortical Cells
Silvia Monticone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Microarray, qPCR, and KCNJ5 Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumors
Elena A. B. Azizan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter
Tobias Akerstrom et al.
PLOS ONE (2012)
Guidelines for the diagnosis and treatment of primary aldosteronism - The Japan Endocrine Society 2009
Tetsuo Nishikawa et al.
ENDOCRINE JOURNAL (2011)
High prevalence of autonomous aldosterone secretion among patients with essential hypertension
Aggeliki Gouli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Murim Choi et al.
SCIENCE (2011)
Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
John W. Funder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Distinguishing the antihypertensive and electrolyte effects of eplerenone
DG Levy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Share Paper
